Park Jeong Hyun, Lee Se Kyung, Lee Jeong Eon, Kim Seok Won, Nam Seok Jin, Kim Ji-Yeon, Ahn Jin-Seok, Park Won, Yu Jonghan, Park Yeon Hee
Strategic Planning Team, Office of Management & Support, Samsung Medical Center, Seoul, Korea.
Division of Breast Surgery, Department of Surgery, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Breast Cancer. 2018 Mar;21(1):91-95. doi: 10.4048/jbc.2018.21.1.91. Epub 2018 Mar 23.
In this study, we aimed to evaluate the economic loss due to the diagnosis of breast cancer within the female South Korean working-age population. A population-based cost analysis was performed for cancer-related diagnoses between 1999 and 2014, using respective public government funded databases. Among the five most common cancers, breast cancer mortality was strongly associated with the growth in gross domestic product between 1999 and 2014 (R=0.98). In the female population, breast cancer represented the greatest productivity loss among all cancers, which was a consequence of the peak in the incidence of breast cancer during mid-working age in the working-age population, in addition to being the most common and fastest growing cancer among South Korean women. Our study shows that breast cancer not only represents a significant disease burden for individual patients, but also contributes a real, nonnegligible loss in productivity in the South Korean economy.
在本研究中,我们旨在评估韩国女性劳动年龄人口中因乳腺癌诊断导致的经济损失。利用政府各自资助的公共数据库,对1999年至2014年期间与癌症相关的诊断进行了基于人群的成本分析。在五种最常见的癌症中,1999年至2014年期间乳腺癌死亡率与国内生产总值增长密切相关(R = 0.98)。在女性人群中,乳腺癌在所有癌症中造成的生产力损失最大,这是由于劳动年龄人口中乳腺癌发病率在中年工作年龄达到峰值,此外乳腺癌也是韩国女性中最常见且增长最快的癌症。我们的研究表明,乳腺癌不仅给个体患者带来了重大疾病负担,也给韩国经济造成了实际且不可忽视的生产力损失。